The Living Will: India’s Most Ignored Wealth Document

You have a Will for your assets. You have a succession plan for your business. You have a trust for your grandchildren. But there is one legal document — legally valid in India since 2018, recognised by the Supreme Court of India, and capable of determining whether you live or die on a ventilator — that not a single member of your wealth advisory team has ever placed before you. It is called an Advance Medical Directive. The world knows it as a Living Will. And for India’s HNI and UHNI community, it may be the most consequential document you have never signed.

The Blind Spot in India’s Wealth Planning Ecosystem

Walk into the office of any top private bank, family office, or independent financial advisor in India today. You will find sophisticated conversations about portfolio construction, estate planning, succession law, offshore trusts, and inter-generational wealth transfer. What you will almost certainly not find is any conversation about what happens when the client — not the portfolio, not the business — becomes incapacitated.

This is not a minor oversight. It is a systemic blind spot.

The financial industry in India has, understandably, focused its advisory infrastructure on the accumulation and transfer of wealth. The entire architecture of wealth management — from portfolio management services to SEBI-registered investment advisers to private wealth divisions of global banks — is oriented around financial instruments, tax efficiency, and asset protection.

What falls entirely outside this architecture is the question of medical decision-making. And for HNIs and UHNIs, the stakes of this omission are enormous.

When a high-net-worth individual is struck by a sudden medical crisis, the vacuum of legal authority over medical decisions can be as catastrophic as the absence of a Will.

Consider a scenario familiar to any senior medical practitioner in India: a 68-year-old founder of a Gujarat-based industrial group suffers a severe stroke. He is in the ICU, unconscious, and incapable of communicating. The attending doctors face an immediate decision about aggressive life-sustaining treatment. The family — adult children with divergent views, a spouse in acute distress, a business partner with his own interests — cannot agree. There is no legal document that speaks for the patient.

In this vacuum, the doctors default to maximum intervention: every machine, every procedure, every month of ICU care — regardless of what the patient may have wished. The costs mount into crores. The dignity of the patient’s final period of life is entirely surrendered. And critically: not one rupee of the family’s carefully structured estate plan addresses this moment.

This is precisely the problem a Living Will — or in Indian legal terminology, an Advance Medical Directive (AMD) — is designed to solve.

What Is a Living Will? The Indian Legal Framework

The term ‘Living Will’ is widely used globally, but its Indian legal avatar carries a specific name and a specific statutory foundation. Under the Mental Healthcare Act, 2017 (MHA 2017) — which came into force on May 29, 2018 — every adult Indian citizen of sound mind has the right to make an Advance Directive specifying their wishes regarding medical treatment in advance.

This right was emphatically affirmed — and its constitutional legitimacy confirmed — by the Supreme Court of India in its landmark constitutional bench judgment in Common Cause v. Union of India, (2018) 5 SCC 1, delivered on March 9, 2018. A five-judge bench, speaking in five separate concurring opinions, unanimously held that the right to refuse unwanted medical treatment is an intrinsic element of the right to life and personal liberty under Article 21 of the Constitution.

In simple terms: you have the right, as a legally competent adult, to decide in advance what medical interventions you do and do not want if you ever lose the capacity to make or communicate decisions. That decision, made in writing, signed, witnessed, and registered before a Judicial Magistrate First Class, constitutes a legally enforceable Advance Medical Directive.

The key legal facts every HNI and their advisors should know:

Governing Law	The Mental Healthcare Act, 2017 (MHA 2017)
Effective Date of MHA	May 29, 2018
Document Name in Law	Advance Medical Directive (AMD) / Advance Directive
Who Can Execute?	Any person above 18 years, of sound mind
Registration	Before a Judicial Magistrate First Class (JMFC)
Witnesses Required	Two independent witnesses present at signing
Medical Counterpart	Medical Board of at least 3 doctors must concur
Revocation	May be revoked at any time by the maker
Nominated Representative	Healthcare proxy who speaks for you if incapacitated
Supreme Court Ruling	Common Cause v. Union of India, (2018) 5 SCC 1

Why This Is a Wealth Planning Issue, Not Just a Medical One

The financial advisory community has, by and large, treated the Living Will as a medical or bioethical matter — interesting, perhaps, but outside the scope of a wealth management conversation. This framing is both understandable and deeply mistaken.

The Financial Cost of Unplanned ICU Care

India’s top private hospitals now charge between Rs. 1 lakh and Rs. 3 lakh per day for ICU care involving advanced life support. A prolonged period of futile treatment — keeping a patient alive in a persistent vegetative state, or with no realistic prospect of recovery — can consume Rs. 50 lakh to Rs. 5 crore or more over weeks and months. These are not theoretical figures. They are documented in the case histories of families who spent their inheritance on ventilators.

For UHNI families with international assets, the costs compound dramatically. Medical evacuation to Singapore or the UK, followed by ICU care at $3,000–$10,000 per day, can trigger financial consequences that dwarf the premiums of any health insurance policy the family holds.

An Advance Directive — by clearly specifying under what conditions the patient does not wish to receive life-sustaining treatment — can prevent this financial catastrophe entirely. It converts a blank cheque of unbounded liability into a defined, dignified, and legally authorised plan.

The Succession and Estate Planning Dimension

Every estate planning lawyer knows that the period of incapacity — the gap between the moment a person loses capacity and the moment they die — is the most legally turbulent period in any succession. In the absence of a Living Will:

• Family members may need to approach courts for guardianship orders, at significant legal cost and reputational exposure.
• Business succession plans may be disrupted if the founder or key decision-maker is incapacitated without a designated healthcare proxy who understands the business context.
• Trusts and estate structures with testamentary instructions may be effectively frozen if the trustee or settlor is in a medically incapacitated state without legal documentation covering that scenario.
• Family disputes over medical decisions — which hospital, which doctor, which treatment — can fracture family relationships precisely at the moment when family unity is most needed for wealth management.

A properly structured AMD, combined with a healthcare proxy designation (the Nominated Representative under MHA 2017), inserts a legally authorised voice into this turbulence. That voice speaks not for the hospital, not for the government, and not for whichever family member is loudest — but for the patient.

The Cross-Border Dimension for Global HNIs

For India’s internationally mobile HNI community — Canadian PRs, UK residents, UAE Golden Visa holders, US Green Card holders, or simply frequent travellers — the Living Will question becomes multilateral. A medical emergency in Singapore operates under Singapore law. An incapacitation in the United Kingdom invokes the Mental Capacity Act 2005. A hospitalisation in the UAE requires engagement with the local healthcare regulation authority.

Competent cross-border wealth planning now requires that clients maintain jurisdiction-specific advance directives — or at minimum, an international version that can be accepted or translated across multiple legal systems. This is a space that barely exists in India’s advisory market today, which is precisely why it represents both a gap and an opportunity.

For India’s globally mobile UHNI community, a single country Living Will is no longer sufficient. Medical incapacity does not respect visa categories.

The Supreme Court Watershed: What Common Cause Means

No understanding of the Indian Living Will landscape is complete without engaging seriously with Common Cause v. Union of India, (2018) 5 SCC 1. This is not merely a medical law case. It is one of the most significant constitutional judgments of the post-2010 era, and it has direct implications for wealth and estate planning.

The Supreme Court in Common Cause recognised three critical principles:

• The right to die with dignity is a fundamental right under Article 21 of the Constitution of India. A person has the right to refuse medical treatment, including life-sustaining treatment, that they do not wish to receive.
• Passive euthanasia — the withdrawal of life support in defined circumstances — is legally permissible in India, subject to a structured process involving a Medical Board and judicial oversight.
• An Advance Medical Directive, made while the person is of sound mind, is the authoritative expression of that person’s autonomous choice, and must be respected by medical practitioners, hospitals, and family members alike.

The Court also acknowledged the procedural complexity it had created, and in 2023, it simplified the registration process in response to widespread concerns that the original procedure was too cumbersome. As of the amended guidelines, the AMD can now be registered before a notary and need not require a JMFC in all cases — though the original procedure remains valid. Legal counsel should advise clients on the current operative process in their jurisdiction.

What Common Cause definitively settled is that the Living Will is not a grey area. It is black-letter constitutional law. Any physician, hospital, or family member who ignores a valid AMD may be acting in violation of a fundamental right. That is a statement with direct legal and financial consequences.

Key Takeaway for Wealth Advisors A Living Will is not a soft lifestyle document. It is a constitutionally grounded legal instrument upheld by a five-judge bench of the Supreme Court of India. Ignoring it in a comprehensive wealth plan is not a conservative approach — it is an oversight with potentially irreversible consequences for your client’s estate, health, and family.

The Five Questions Every HNI Should Ask — and Most Cannot Answer

Here is a simple diagnostic that any financial advisor can pose to a client in the next meeting:

• If you are ever in a coma with no realistic prospect of recovery, do you want to be kept alive on a ventilator indefinitely? Yes or No?
• If you lose the ability to communicate permanently, who has the legal authority to speak for you on medical matters — and do they have a document that says so?
• If you are hospitalised abroad and incapacitated, does your estate plan include any mechanism for foreign medical decision-making?
• Have you ever discussed with your family — on the record, in a legally witnessed format — what you consider a meaningful quality of life?
• If you are unconscious in an ICU for six months, what is the total financial liability exposure to your estate, and who bears it?

The overwhelming majority of India’s wealthiest individuals — people whose financial affairs are managed with extraordinary sophistication — cannot answer these five questions with any legal certainty. Their wills are in order. Their trusts are structured. Their offshore accounts are compliant. But when it comes to the most basic question of what happens to them as human beings in a medical emergency, there is silence.

That silence is not philosophical. It is a legal and financial vulnerability.

What an Advance Medical Directive Actually Contains

A well-drafted AMD for an Indian HNI is not a one-page wish list. It is a substantive legal document that typically addresses:

• Trigger conditions: The specific medical circumstances under which the directive activates — typically including terminal illness with no reasonable prospect of recovery, persistent vegetative state, and end-stage organ failure.
• Treatment refusal instructions: Specific treatments the person does not wish to receive, such as cardiopulmonary resuscitation (CPR), mechanical ventilation, dialysis, artificial nutrition, or invasive surgical intervention in futility contexts.
• Treatment consent instructions: Circumstances in which the person affirmatively consents to specific treatments, including palliative care, pain management, and comfort-focused care.
• Nominated Representative: A designated healthcare proxy — typically a spouse, adult child, or trusted friend — with the authority to speak for the patient when they cannot speak for themselves. This person must be of sound mind, above 18, and willing to accept the responsibility.
• Medical professional guidance: Instructions to the attending physician, the hospital medical board, and any ethics committee regarding the interpretation of the document.
• Revocation clause: A statement of the person’s right to revoke or amend the AMD at any time while they retain capacity.

For UHNIs with international exposure, the document should also include a statement of the person’s habitual residence and nationality, a clause addressing cross-border applicability, and ideally a coordinated parallel document under the law of the relevant foreign jurisdiction.

The legal quality of the AMD matters enormously. A poorly drafted document — ambiguous trigger conditions, undefined clinical terms, a Nominated Representative with no guidance on how to exercise their authority — is worse than no document at all, because it creates the illusion of legal protection without the substance.

The Role of the Wealth Advisor: An Untapped Conversation

The question is not whether India’s HNI clients need Living Wills. They do. The question is who facilitates that conversation.

At present, the conversation falls into a gap between professions. The family physician does not consider it their role to raise legal documents. The estate planning lawyer may mention it briefly in the context of a comprehensive succession plan but rarely has the medical literacy to draft it properly. The financial planner does not consider it their domain at all. And the client — faced with the psychological discomfort of confronting their own mortality — rarely initiates the conversation themselves.

This gap is an opportunity for forward-thinking advisors who are willing to take a genuinely holistic view of their clients’ needs. The advisor who introduces the Living Will conversation is not venturing into unfamiliar territory — they are completing the wealth planning picture. They are the advisor who gets the conversation that counts.

The AMD conversation also opens doors that are otherwise closed. It leads naturally to a deeper engagement with the client’s values — their conception of a good life, their views on medical intervention, their family dynamics, their international mobility, and their long-term intentions. These are the conversations from which enduring advisory relationships are built.

For Estate Planning Professionals Consider adding the AMD as a standard module in every comprehensive estate plan above a defined threshold. The document is not complex to produce. What requires expertise is the legal drafting, the registration process, and the coordination with the client’s medical team and Nominated Representative. This is a service gap that trained legal and advisory teams can fill — and that clients will remember.

The Process: How to Execute an Advance Medical Directive in India

Executing a valid AMD in India currently involves the following steps, consistent with MHA 2017 and the Supreme Court’s simplified 2023 guidelines:

• Legal Drafting: Retain a qualified advocate — ideally with experience in medico-legal matters and an understanding of the relevant clinical terminology — to draft the AMD in accordance with MHA 2017 and the Supreme Court guidelines.
• Medical Consultation: Discuss the document with your primary physician or a palliative care specialist. Ensure that the clinical conditions and treatment decisions described in the AMD are medically coherent and reflect an informed understanding of the relevant conditions.
• Execution and Witnessing: Sign the AMD in the presence of two independent witnesses who are not the Nominated Representative, are not related to the maker by blood or marriage, and have no financial stake in the outcome.
• Countersignature of a Gazetted Officer or Notary: As per the Supreme Court’s 2023 simplification, a notary or gazetted officer may now countersign the document. The original JMFC procedure also remains available and may be preferred in some jurisdictions for additional legal certainty.
• Custody and Distribution: Retain the original, provide a certified copy to the Nominated Representative, provide a copy to the primary physician, and if possible, register a copy with the local medical authority or a national registry. Ensure the document is accessible in a medical emergency.
• Periodic Review: The AMD is not a static document. Review it every three to five years, or following any significant change in health status, family circumstances, or personal values.

The Conversation India’s Wealthy Families Need to Have

India is entering a period of unprecedented intergenerational wealth transfer. Over the next two decades, an estimated $8 trillion in assets is expected to pass from the founding generation to the next. The planning infrastructure for this transfer is rapidly professionalising: family offices are multiplying, succession laws are being studied, philanthropic vehicles are being structured.

But no amount of financial sophistication insulates a family from the moment when the patriarch or matriarch lies in an ICU, unable to speak, with the family frozen in anguish and the medical team acting on the default of maximum intervention.

The Living Will — the Advance Medical Directive — is the document that inserts the person back into that moment. It is the final act of autonomy. It says: I have thought about this. I have decided. This is my voice, even when I have no voice.

For India’s wealth planning industry, the Living Will is not a peripheral concern. It is the missing document in every comprehensive wealth plan. The families who execute it thoughtfully will face that ICU moment — if it comes — with legal clarity, financial protection, and the profound comfort of knowing that the person they love is being treated as they wished.

That is not a medical conversation. That is the most important wealth planning conversation you can have.

The Will protects your assets. The Living Will protects you.

About the Author

Prashant Ajmera is the Founder and Advocate at Ajmera Law International (ALI), a cross-border law firm established in 1993 and headquartered in Ahmedabad with a presence in Dubai. He holds a B.Sc., LL.M. (India), and ICSA (UK) and is a Canadian citizen. He is the author of ‘Millionaires On the Move’ (2019) and ‘How to Plan for Child’s Foreign Education’ (2020). His firm’s Advance Medical Directive practice serves HNI and UHNI families across India with medico-legal advisory, AMD drafting, registration coordination, and cross-border Living Will alignment. He is also the founder of the Lawyers for Organ Donation Law (LODL) network and co-founder of OneIndiaOneLaw.org.

Contact: prashant@ajmeralaw.com  |  +91 98986 98184  |  www.ajmeralaw.com

 

This article is for general information and public awareness purposes only and does not constitute legal or medical advice. Readers should consult qualified legal counsel and medical professionals before executing an Advance Medical Directive.